1 – 4 of 4
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
(
- Contribution to journal › Article
-
Mark
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
(
- Contribution to journal › Article
- 2016
-
Mark
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations
(
- Contribution to journal › Article
- 2008
-
Mark
Overall Survival (OS) and New Patterns of Response in Patients (Pts) With Advanced Melanoma Treated With Ipilimumab
2008) 23rd Annual Meeting of the International-Society-for-Biological-Therapy-of-Cancer In Journal of Immunotherapy 31(9). p.937-938(
- Contribution to journal › Published meeting abstract